High FDA official overrules workers to approve gene remedy that failed trial – Model Slux
Enlarge / Dr. Peter Marks, Director of the Heart for Biologics Analysis and Analysis inside the Meals and Drug Administration on March 18, 2021 in Washington, DC. The Meals and Drug Administration (FDA) on Thursday introduced expanded approval for a gene remedy to deal with Duchenne muscular dystrophy (DMD)—even if it failed a Section III … Read more
